Company / Debt per Share
Centessa Pharmaceuticals plc Debt per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.74
FY2025
5-year range
$0.00 / $1.01
FY2021-FY2025
Trend
-10.2%
vs FY2024
Sector context
#66 of 82
Health Care
What the data says
Centessa Pharmaceuticals plc's debt per share of $0.74 is lower than 80% of companies in the Health Care sector (FY2025). Increased from $0.00 to $0.74 over the past 2 years.
Based on SEC 10-K filings.
0.74 in FY2025 with a 3-year CAGR of -0.4%.
Increased from $0.00 to $0.74 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -0.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 82This company $0.74 Sector average $151.48
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 10.2% year-over-year.
- Ranks #66 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2021.
- Lowest debt per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.74 | -10.2% |
| FY2024 | $0.82 | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $0.75 | -25.8% |
| FY2021 | $1.01 | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026